News|Articles|October 10, 2025
FDA Action Update, September 2025: Complete Response Letters and Extension of Review Time
Author(s)Isabella Ciccone, MPH
Catch up on any of the neurology news headlines you may have missed in September 2025, compiled into 1 place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in September 2025, making a number of decisions on potential new therapeutic agents, including issuing complete response letters and giving an extension for review time.
Advertisement
Advertisement